title: Determination of optimal fiducial marker across image-guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers.
abstract: The purpose of this study was to evaluate the visibility and artifact created by gold, carbon, and polymer fiducial markers in a simple phantom across computed tomography (CT), kilovoltage (kV), and megavoltage (MV) linear accelerator imaging and MV tomotherapy imaging. Three types of fiducial markers (gold, carbon, and polymer) were investigated for their visibility and artifacts in images acquired with various modalities and with different imaging parameters (kV, mAs, slice thickness). The imaging modalities include kV CT, 2D linac-based kilovoltage and megavoltage X-ray imaging systems, kV cone-beam CT, and normal and fine tomotherapy imaging. The images were acquired on a phantom constructed using Superflab bolus in which markers of each type were inserted into the center layer. The visibility and artifacts produced by each marker were assessed qualitatively and quantitatively. All tested markers could be identified clearly on the acquired CT and linac-based kV images; gold markers demonstrated the highest contrast. On the CT images, gold markers produced a significant artifact, while no artifacts were observed with polymer markers. Only gold markers were visible when using linac-based MV and tomotherapy imaging. For linac-based kV images, the contrast increased with kV and mAs values for all the markers, with the gold being the most pronounced. On CT images, the contrast increased with kV for the gold markers, while decreasing for the polymer and carbon marker. With the bolus phantom used, we found that when kV imaging-based treatment verification equipment is available, polymer and carbon markers may be the preferred choice for target localization and patient treatment positioning verification due to less image artifacts. If MV imaging will be the sole modality for positioning verification, it may be necessary to use gold markers despite the artifacts they create on the simulation CT images.
authors.affiliation: Department of Radiation Oncology, The Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA.
authors.forename: Lydia L
authors.initials: LL
authors.lastname: Handsfield
authors.forename: Ning J
authors.initials: NJ
authors.lastname: Yue
authors.forename: Jinghao
authors.initials: J
authors.lastname: Zhou
authors.forename: Ting
authors.initials: T
authors.lastname: Chen
authors.forename: Sharad
authors.initials: S
authors.lastname: Goyal
mesh_terms: D016477:Artifacts; D002244:Carbon / Q000032:analysis*; D057918:Fiducial Markers; D006046:Gold / Q000032:analysis*; D006801:Humans; D010315:Particle Accelerators / Q000295:instrumentation; D019047:Phantoms, Imaging; D011108:Polymers / Q000032:analysis*; D061089:Radiotherapy, Image-Guided; D014057:Tomography, X-Ray Computed
chemical_list: D011108:Polymers; D002244:Carbon; D006046:Gold